...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status
【24h】

Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status

机译:化疗耐药患者的3种B细胞淋巴瘤细胞系在体外对21种抗肿瘤药的敏感性,ABC转运蛋白表达和细胞氧化还原状态方面的表征

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to characterize three new, recently established non-Hodgkin lymphoma cell lines (GUMBUS, DOGUM, and DOGKIT), isolated from patients developing high-clinical resistance to cytotoxic therapy, with respect to sensitivity toward 21 antitumor drugs from different classes of action, expression of three ABC transporters: P glycoprotein (Pgp) (MDR1 and ABCB1), multidrug resistance related proteins (MRP1) (ABCC1), and MRP2 (ABCC2), as well as a range of antioxidative enzymes and glutathione (GSH). The results were compared to analogous data from the well-known HL-60 and U-937 cells.
机译:这项研究的目的是鉴定三种新近建立的非霍奇金淋巴瘤细胞系(GUMBUS,DOGUM和DOGKIT),这些细胞系从对细胞毒性疗法产生高临床耐药性的患者中分离出来,并且对来自21种不同抗癌药物的敏感性作用类别,三种ABC转运蛋白的表达:P糖蛋白(Pgp)(MDR1和ABCB1),多药耐药相关蛋白(MRP1)(ABCC1)和MRP2(ABCC2),以及一系列抗氧化酶和谷胱甘肽(GSH) )。将结果与来自著名的HL-60和U-937细胞的类似数据进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号